首页|基于TRPA1离子通道蛋白的支气管哮喘病理机制及中医药干预现代研究进展

基于TRPA1离子通道蛋白的支气管哮喘病理机制及中医药干预现代研究进展

扫码查看
哮喘是一种反复发作的气道阻塞和喘息为特征的气道慢性炎症性疾病,瞬时受体电位锚蛋白1(Transient Receptor Potential Al,TRPA1)离子通道存在于多种组织细胞中,参与调节气道功能和炎症.以往对于TRPA1的研究更多的是在疼痛领域,尚未对相关调控离子蛋白通道表达治疗支气管哮喘的病理机制及中医药治疗进展做系统阐述.查阅国内外相关文献资料发现,在哮喘发生发展过程中,TRPA1离子通道蛋白参与气道炎症、气道高反应等病理过程.因此调控TRPA1离子蛋白通道的表达有利于治疗支气管哮喘.目前西医的治疗手段主要以吸入糖皮质激素与支气管扩张剂联合治疗为主,但部分患者不能达到完全控制,中医药在治疗哮喘方面具有靶点多、作用广、疗效优等特点,具有祛痰平喘、宣肺下气的中药及复方可以通过抗炎等作用有效调控TRPA1在体内的表达.文章总结TRPA1离子通道蛋白及其与支气管哮喘的关系,并就近年来中医药调控TRPA1的表达治疗支气管哮喘的研究进展进行综述,以期为基于TRPA1探讨支气管哮喘新的病理机制奠定实验室基础,为支气管哮喘防治及相关中药新药研发提供新的作用靶点与研究方向.
Research Progress on Pathological Mechanisms and Traditional Chinese Medicine Interventions of Bronchial Asthma Based on TRPA1 Ion Channel Protein
Asthma is a chronic inflammatory disease of the airways characterized by recurrent airway obstruction and wheezing. Transient Receptor Potential Al (TRPA1) ion channels exist in a variety of tissue cells and are involved in regu-lation. Airway function and inflammation. Previous research on TRPA1 was mostly in the field of pain, and the pathological mechanism of related regulation of ion protein channel expression in the treatment of bronchial asthma and the progress of traditional Chinese medicine treatment have not yet been systematically elucidated. A review of relevant literature at home and abroad found that during the occurrence and development of asthma, the TRPA1 ion channel protein is involved in pathological processes such as airway inflammation and airway hyperresponsiveness. Therefore, regulating the expres-sion of TRPA1 ion protein channel is beneficial to the treatment of bronchial asthma. At present, the treatment methods of Western medicine are mainly combined with inhaled glucocorticoids and bronchodilators, but some patients cannot achieve complete control. Traditional Chinese medicine has the characteristics of multiple targets, wide range of effects, and excellent curative effect in the treatment of asthma. Traditional Chinese medicine and compound prescriptions for asthma, Xuanfei and Qi can effectively regulate the expression of TRPA1 in the body through anti-inflammatory and other effects. This article summarizes the TRPA1 ion channel protein and its relationship with bronchial asthma, and reviews the research progress of traditional Chinese medicine in regulating the expression of TRPA1 in the treatment of bronchial asthma in recent years, in order to lay a laboratory foundation for exploring new pathological mechanisms of bronchial asthma based on TRPA1, and provide guidance for bronchial asthma. The prevention and treatment of asthma and the de-velopment of related new traditional Chinese medicines provide new targets and research directions.

AsthmaTransient receptor potential ankyrin 1 ion channelInflammationTraditional Chinese medicine

白今、王强

展开 >

天津中医药大学 天津 301617

天津中医药大学第二附属医院 天津 300250

哮喘 瞬时受体电位锚蛋白1离子通道 炎症 中医药

天津市高等学校创新团队培养计划天津市高等学校中青年骨干创新人才培养计划

TD13-5051津教委人函[2017]23号

2024

中医药临床杂志
中华中医药学会

中医药临床杂志

影响因子:0.636
ISSN:1672-7134
年,卷(期):2024.36(4)
  • 70